GL1X · GenesisL1 explorer

MolNFT v1 · #190513 · protein

The crystal structure of SARS-cov-2 omicron BA.1 variant rbd in complex with equine ACE2

7XBY · Angiotensin-converting enzyme: “The crystal structure of SARS-cov-2 omicron BA.1 variant rbd in complex with equine ACE2”. X-ray diffraction, 3 ligands (NAG, ZN, BR), 5 pockets (best druggability 0.66). MolNFT v1 #190513 on…

PDB
7XBY
Type
protein
Length
791 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensin-converting enzyme; Spike protein S1
EC
3.4.-.-
UniProt
F6V9L3, P0DTC2
Ligands
NAG, ZN, BR
Pockets
5 · best druggability 0.66

Structure

x-ray diffraction · 2 distinct chains · 51% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAngiotensin-converting enzyme (EC 3.4.-.-)protein59663% helix, 5% strandF6V9L3
BSpike protein S1protein19515% helix, 27% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains B
  • ZN · Zinc ion · metal · chains A
  • BR · Bromide ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14670.660.7837empty
25810.640.7555empty
34800.620.7669empty
4950.470.8018NAG
5560.270.7316empty

Interfaces

1 interface between chains.

  • A–B · 882 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 7XBY · The crystal structure of SARS-CoV-2 Omicron BA.1 variant RBD in complex with equine ACE2 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.